Literature DB >> 22775406

Effects of independent and substance-induced major depressive disorder on remission and relapse of alcohol, cocaine and heroin dependence.

Sharon Samet1, Miriam C Fenton, Edward Nunes, Eliana Greenstein, Efrat Aharonovich, Deborah Hasin.   

Abstract

AIMS: Little is known about the differential effects of independent and substance-induced major depression on the longitudinal course of alcohol, cocaine and heroin disorders when studied prospectively.
DESIGN: Consecutively admitted in-patients, evaluated at baseline, 6-, 12- and 18-month follow-ups.
SETTING: Baseline evaluations in a short-stay in-patient urban community psychiatric hospital unit. PARTICIPANTS: Adults (n = 250) with current DSM-IV cocaine, heroin and/or alcohol dependence at baseline. MEASUREMENTS: The Psychiatric Research Interview for Substance and Mental Disorders (PRISM), used to evaluate independent and substance-induced major depression, alcohol, cocaine and heroin dependence, and other psychiatric disorders. Outcomes for each substance: (i) time (weeks) from hospital discharge to first use; (ii) time from discharge to onset of sustained (≥26 weeks) remission from dependence; (iii) time from onset of sustained remission to relapse.
FINDINGS: Substance-induced major depression significantly predicted post-discharge use of alcohol, cocaine and heroin (hazard ratios 4.7, 5.3 and 6.5, respectively). Among patients achieving stable remissions from dependence, independent major depression predicted relapse to alcohol and cocaine dependence (hazard ratios 2.3 and 2.7, respectively).
CONCLUSIONS: Substance-induced and independent major depressions were both related to post-discharge use of alcohol, cocaine and heroin. The findings suggest the importance of clinical attention to both types of depression in substance abusing patients.
© 2012 The Authors, Addiction © 2012 Society for the Study of Addiction.

Entities:  

Mesh:

Year:  2012        PMID: 22775406      PMCID: PMC3767419          DOI: 10.1111/j.1360-0443.2012.04010.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  58 in total

1.  Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement.

Authors:  K M Carroll; S A Ball; C Nich; P G O'Connor; D A Eagan; T L Frankforter; E G Triffleman; J Shi; B J Rounsaville
Journal:  Arch Gen Psychiatry       Date:  2001-08

2.  Test-retest reliability of the cognitive lifetime drinking history.

Authors:  M Russell; J R Marshall; M Trevisan; J L Freudenheim; A W Chan; N Markovic; J E Vána; R L Priore
Journal:  Am J Epidemiol       Date:  1997-12-01       Impact factor: 4.897

3.  Depression among cocaine abusers in treatment: relation to cocaine and alcohol use and treatment outcome.

Authors:  R A Brown; P M Monti; M G Myers; R A Martin; T Rivinus; M E Dubreuil; D J Rohsenow
Journal:  Am J Psychiatry       Date:  1998-02       Impact factor: 18.112

4.  Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial.

Authors:  Stephanie S O'Malley; Rajita Sinha; Carlos M Grilo; Christy Capone; Conor K Farren; Sherry A McKee; Bruce J Rounsaville; Ran Wu
Journal:  Alcohol Clin Exp Res       Date:  2007-04       Impact factor: 3.455

5.  Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Kevin P Conway; Wilson Compton; Frederick S Stinson; Bridget F Grant
Journal:  J Clin Psychiatry       Date:  2006-02       Impact factor: 4.384

Review 6.  Alcohol and depression.

Authors:  Joseph M Boden; David M Fergusson
Journal:  Addiction       Date:  2011-03-07       Impact factor: 6.526

7.  Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

Authors:  Raymond F Anton; Stephanie S O'Malley; Domenic A Ciraulo; Ron A Cisler; David Couper; Dennis M Donovan; David R Gastfriend; James D Hosking; Bankole A Johnson; Joseph S LoCastro; Richard Longabaugh; Barbara J Mason; Margaret E Mattson; William R Miller; Helen M Pettinati; Carrie L Randall; Robert Swift; Roger D Weiss; Lauren D Williams; Allen Zweben
Journal:  JAMA       Date:  2006-05-03       Impact factor: 56.272

8.  Helping other alcoholics in alcoholics anonymous and drinking outcomes: findings from project MATCH.

Authors:  Maria E Pagano; Karen B Friend; J Scott Tonigan; Robert L Stout
Journal:  J Stud Alcohol       Date:  2004-11

9.  Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial.

Authors:  David McDowell; Edward V Nunes; Angela M Seracini; Jami Rothenberg; Suzanne K Vosburg; Guoguang J Ma; Eva Petkova
Journal:  Drug Alcohol Depend       Date:  2005-11-01       Impact factor: 4.492

Review 10.  Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis.

Authors:  Edward V Nunes; Frances R Levin
Journal:  JAMA       Date:  2004-04-21       Impact factor: 56.272

View more
  20 in total

1.  Heroin refusal self-efficacy and preference for medication-assisted treatment after inpatient detoxification.

Authors:  Shannon R Kenney; Genie L Bailey; Bradley J Anderson; Michael D Stein
Journal:  Addict Behav       Date:  2017-05-09       Impact factor: 3.913

2.  Managing dual disorders: a statement by the Informal Scientific Network, UN Commission on Narcotic Drugs.

Authors:  Nora D Volkow; Marta Torrens; Vladimir Poznyak; Elizabeth Sáenz; Anja Busse; Wataru Kashino; Dzmitry Krupchanka; Devora Kestel; Giovanna Campello; Gilberto Gerra
Journal:  World Psychiatry       Date:  2020-10       Impact factor: 49.548

3.  Depressive symptoms mediate the relationship between changes in emotion regulation during treatment and abstinence among women with alcohol use disorders.

Authors:  Cathryn Glanton Holzhauer; Stephanie A Gamble
Journal:  Psychol Addict Behav       Date:  2017-04-03

4.  The relationship between perceived stress and depression in substance use disorder treatment.

Authors:  R Kathryn McHugh; Dawn E Sugarman; Laurel Meyer; Garrett M Fitzmaurice; Shelly F Greenfield
Journal:  Drug Alcohol Depend       Date:  2019-12-23       Impact factor: 4.492

5.  Psychiatric and substance use disorders in a predominately low-income, black sample in early midlife.

Authors:  Christina F Mondi; Alison Giovanelli; Suh-Ruu Ou; Arthur J Reynolds
Journal:  J Psychiatr Res       Date:  2022-02-16       Impact factor: 4.791

6.  The Impact of Depressive Symptoms on Response to Integrated Cognitive Behavioral Therapy for Substance Use Disorders and Intimate Partner Violence.

Authors:  Lourah M Kelly; Cory A Crane; Kristyn Zajac; Caroline J Easton
Journal:  Adv Dual Diagn       Date:  2021-05-21

7.  Depressive Symptoms at HIV Testing and Two-Year All-Cause Mortality Among Men Who Inject Drugs in Vietnam.

Authors:  Sara N Levintow; Brian W Pence; Tran Viet Ha; Nguyen Le Minh; Teerada Sripaipan; Carl A Latkin; Pham The Vu; Vu Minh Quan; Constantine Frangakis; Vivian F Go
Journal:  AIDS Behav       Date:  2019-03

8.  Mediational Pathways Among Trait Impulsivity, Heroin-use Consequences, and Current Mood State.

Authors:  Holly H Reid; Leslie H Lundahl; Jamey J Lister; Eric A Woodcock; Mark K Greenwald
Journal:  Addict Res Theory       Date:  2018-01-31

9.  A Biomarker to Differentiate between Primary and Cocaine-Induced Major Depression in Cocaine Use Disorder: The Role of Platelet IRAS/Nischarin (I1-Imidazoline Receptor).

Authors:  Benjamin Keller; Joan-Ignasi Mestre-Pinto; María Álvaro-Bartolomé; Diana Martinez-Sanvisens; Magí Farre; M Julia García-Fuster; Jesús A García-Sevilla; Marta Torrens
Journal:  Front Psychiatry       Date:  2017-12-01       Impact factor: 4.157

10.  Dual Depression: A Sex Perspective.

Authors:  Adriana Farré; Judit Tirado-Muñoz; Marta Torrens
Journal:  Addict Disord Their Treat       Date:  2017-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.